Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France

NCT06355323 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT06355323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06355323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France
Lead sponsor
CHU de Reims
Phase
Not applicable
Overall status
Completed
Start date
November 28, 2022
Completion date
March 11, 2024
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common variable immunodeficiency, igg subclass deficiency, primary immunodeficiency, selective igm deficiency